EVOLUS, INC. (EOLS) ROE
- 2026-06-30: ROE 111.10%.
- 2026-03-31: ROE 150.87%.
- 2025-12-31: ROE 223.50%.
- 2025-09-30: ROE 203.62%.
Complete source-backed roe history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | 111.10% |
|---|
| 2026-03-31 | 150.87% |
|---|
| 2025-12-31 | 223.50% |
|---|
| 2025-09-30 | 203.62% |
|---|
| 2025-06-30 | 332.38% |
|---|
| 2025-03-31 | 851.04% |
|---|
| 2024-12-31 | -913.07% |
|---|
| 2024-09-30 | -941.60% |
|---|
| 2024-06-30 | -275.52% |
|---|
| 2024-03-31 | -325.34% |
|---|
| 2023-12-31 | 298.15% |
|---|
| 2023-09-30 | 325.37% |
|---|
| 2023-06-30 | 953.20% |
|---|
| 2023-03-31 | -1031.83% |
|---|
| 2022-12-31 | -402.25% |
|---|
| 2022-09-30 | -271.82% |
|---|
| 2022-06-30 | -167.69% |
|---|
| 2022-03-31 | -105.15% |
|---|
| 2021-12-31 | -57.17% |
|---|
| 2021-09-30 | -143.04% |
|---|
| 2021-06-30 | -123.76% |
|---|
| 2021-03-31 | -587.73% |
|---|
| 2020-12-31 | 223.43% |
|---|
| 2020-09-30 | -190.42% |
|---|
| 2020-06-30 | -188.87% |
|---|
| 2020-03-31 | -157.80% |
|---|
| 2019-12-31 | -113.31% |
|---|
| 2019-09-30 | -516.15% |
|---|
| 2019-06-30 | -176.81% |
|---|
| 2019-03-31 | -68.58% |
|---|
| 2018-12-31 | -55.54% |
|---|
| 2018-09-30 | -31.57% |
|---|
| 2018-06-30 | -54.78% |
|---|
| 2018-03-31 | -12.78% |
|---|
| 2017-12-31 | 5.93% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | 223.50% |
|---|
| 2024-12-31 | -913.07% |
|---|
| 2023-12-31 | 298.15% |
|---|
| 2022-12-31 | -402.25% |
|---|
| 2021-12-31 | -57.17% |
|---|
| 2020-12-31 | 223.43% |
|---|
| 2019-12-31 | -113.31% |
|---|
| 2018-12-31 | -55.54% |
|---|
| 2017-12-31 | 5.93% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
|---|
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
|---|
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
|---|